EUVIMEDEUVIMED entdecken
Crossref

Emerging insights into TL1A biology may guide precision therapy for IBD

Silvia Pires iD, Wei Yang iD, Randy S Longman iD

Journal of Experimental Medicine · 07.09.2026 · 223 (9)

DOI: 10.1084/jem.20260874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 06.08.2026. Verfasst von Silvia Pires und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jill Roberts Center and Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Precision Medicine, Tumor Necrosis Factor Ligand Superfamily Member 15. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic blocking antibodies against TNF-like cytokine 1A (TL1A) are emerging as one of the most compelling targets in inflammatory bowel disease (IBD). Preliminary phase 2 studies using TL1A-blocking antibodies have demonstrated some of the highest response rates seen in UC and CD. As the field waits for definitive phase 3 study results, the first of which are expected this summer, mechanistic data continue to expand the biological scope of TL1A in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesPrecision MedicineTumor Necrosis Factor Ligand Superfamily Member 15AnimalsHumansAntibodies, Monoclonal

Substanzen

Antibodies, MonoclonalTNFSF15 protein, humanTumor Necrosis Factor Ligand Superfamily Member 15

Autor:innen und Institutionen

  • Department of Medicine, Jill Roberts Center and Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, New York, NY, USA.

ORCID-Profile: Silvia Pires, Wei Yang, Randy S Longman

Zitieren

APA

Pires, S., Yang, W., & Longman, R. S. (2026). Emerging insights into TL1A biology may guide precision therapy for IBD. Journal of Experimental Medicine, 223(9). https://doi.org/10.1084/jem.20260874

Vancouver

Pires S, Yang W, Longman RS. Emerging insights into TL1A biology may guide precision therapy for IBD. Journal of Experimental Medicine. 2026;223(9). doi:10.1084/jem.20260874

BibTeX
@article{Pires2026,
  author = {Pires, Silvia and Yang, Wei and Longman, Randy S},
  title = {Emerging insights into TL1A biology may guide precision therapy for IBD},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {9},
  doi = {10.1084/jem.20260874}
}
Kostenlos starten →